InflaRx NV (IFRX)
2.06
+0.02
(+0.98%)
USD |
NASDAQ |
Nov 21, 16:00
2.10
+0.04
(+1.94%)
After-Hours: 20:00
InflaRx Enterprise Value: 55.47M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 55.47M |
| November 19, 2024 | 48.40M |
| November 18, 2024 | 37.80M |
| November 15, 2024 | 50.17M |
| November 14, 2024 | 54.88M |
| November 13, 2024 | 36.03M |
| November 12, 2024 | 24.26M |
| November 11, 2024 | 25.44M |
| November 08, 2024 | 27.20M |
| November 07, 2024 | 24.26M |
| November 06, 2024 | 25.44M |
| November 05, 2024 | 29.56M |
| November 04, 2024 | 27.20M |
| November 01, 2024 | 28.38M |
| October 31, 2024 | 26.61M |
| October 30, 2024 | 27.79M |
| October 29, 2024 | 27.50M |
| October 28, 2024 | 27.79M |
| October 25, 2024 | 27.79M |
| October 24, 2024 | 29.56M |
| October 23, 2024 | 23.08M |
| October 22, 2024 | 26.02M |
| October 21, 2024 | 25.44M |
| October 18, 2024 | 28.97M |
| October 17, 2024 | 26.61M |
| Date | Value |
|---|---|
| October 16, 2024 | 24.26M |
| October 15, 2024 | 22.49M |
| October 14, 2024 | 23.67M |
| October 11, 2024 | 24.26M |
| October 10, 2024 | 21.31M |
| October 09, 2024 | 22.49M |
| October 08, 2024 | 23.67M |
| October 07, 2024 | 25.44M |
| October 04, 2024 | 27.20M |
| October 03, 2024 | 27.20M |
| October 02, 2024 | 25.44M |
| October 01, 2024 | 24.26M |
| September 30, 2024 | 25.44M |
| September 27, 2024 | 12.06M |
| September 26, 2024 | 10.30M |
| September 25, 2024 | 9.12M |
| September 24, 2024 | 10.30M |
| September 23, 2024 | 6.765M |
| September 20, 2024 | 10.89M |
| September 19, 2024 | 9.12M |
| September 18, 2024 | 4.998M |
| September 17, 2024 | 4.409M |
| September 16, 2024 | 4.998M |
| September 13, 2024 | 3.820M |
| September 12, 2024 | 4.409M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-81.07M
Minimum
Nov 22 2019
226.41M
Maximum
May 01 2023
21.38M
Average
7.714M
Median
Jun 24 2024
Enterprise Value Benchmarks
| Affimed NV | 25.74M |
| BioNTech SE | 7.557B |
| Immatics NV | 373.49M |
| CureVac NV | -45.48M |
| ATAI Life Sciences NV | 192.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.19M |
| Revenue (Quarterly) | 0.1362M |
| Total Expenses (Quarterly) | 17.03M |
| EPS Diluted (Quarterly) | -0.3299 |
| Profit Margin (Quarterly) | -14.09K% |
| Earnings Yield | -51.17% |
| Normalized Earnings Yield | -47.96 |